Pharmacokinetic Study to Evaluate Progesterone Vaginal Rings

Study Title
A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women
Teva Identifier
DR201-BE-10021
ClinicalTrials.gov Identifier
NCT02092571
Study Status
Completed
Trial Condition(s)
Pharmacokinetics
Interventions
Drug: Progesterone vaginal ring,

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female
Age Range
40 Years to 70 Years
Trial Duration
02/01/2014 - 08/01/2014
Phase
Phase 1

Study Type

Interventional